Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

Marco P. Donadini, Walter Ageno
2022 Bleeding, Thrombosis, and Vascular Biology  
For almost 90 years, the discovery and development of anticoagulant drugs have focused on maximizing their antithrombotic efficacy while minimizing the risk of bleeding, in addition to providing manageable compounds with predictable and/or monitorable effects [...].
doi:10.4081/btvb.2022.22 fatcat:a3wi5fxvsrgsxl7jgnn2lrnbeq